SARS-CoV-2 strategically mimics proteolytic activation of human ENaC P Anand, A Puranik, M Aravamudan, AJ Venkatakrishnan, ... Elife 9, e58603, 2020 | 137 | 2020 |
Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis T Wagner, FNU Shweta, K Murugadoss, S Awasthi, AJ Venkatakrishnan, ... Elife 9, e58227, 2020 | 130* | 2020 |
On the Origins of Omicron’s Unique Spike Gene Insertion AJ Venkatakrishnan, P Anand, PJ Lenehan, R Suratekar, B Raghunathan, ... Vaccines 10 (9), 1509, 2022 | 80* | 2022 |
Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA vaccines for COVID-19 from Moderna and Pfizer/BioNtech R McMurry, P Lenehan, S Awasthi, E Silvert, A Puranik, C Pawlowski, ... Med (N Y), 965-978.e5, 2021 | 60* | 2021 |
Global importance analysis: An interpretability method to quantify importance of genomic features in deep neural networks PK Koo, A Majdandzic, M Ploenzke, P Anand, SB Paul PLOS Computational Biology 17 (5), e1008925, 2021 | 50 | 2021 |
ABS–Scan: in silico alanine scanning mutagenesis for binding site residues in protein–ligand complex P Anand, D Nagarajan, S Mukherjee, N Chandra F1000Research 3, 2014 | 46 | 2014 |
Benchmarking evolutionary tinkering underlying human–viral molecular mimicry shows multiple host pulmonary–arterial peptides mimicked by SARS-CoV-2 AJ Venkatakrishnan, N Kayal, P Anand, AD Badley, GM Church, ... Cell Death Discovery 6 (1), 1-14, 2020 | 43 | 2020 |
Structural annotation of Mycobacterium tuberculosis proteome P Anand, S Sankaran, S Mukherjee, K Yeturu, R Laskowski, A Bhardwaj, ... PloS one 6 (10), e27044, 2011 | 43 | 2011 |
Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL P Anand, A Guillaumet-Adkins, V Dimitrova, H Yun, Y Drier, N Sotudeh, ... Blood, The Journal of the American Society of Hematology 137 (18), 2463-2480, 2021 | 41 | 2021 |
PLIC: protein–ligand interaction clusters P Anand, D Nagarajan, S Mukherjee, N Chandra Database 2014, 2014 | 37 | 2014 |
COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational variance M Niesen, P Anand, E Silvert, R Suratekar, C Pawlowski, P Ghosh, ... medRxiv, 2021 | 31 | 2021 |
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma J Frede, P Anand, N Sotudeh, RA Pinto, MS Nair, H Stuart, AJ Yee, ... Nature Cell Biology, 1-13, 2021 | 28 | 2021 |
FMRP interacts with C/D box snoRNA in the nucleus and regulates ribosomal RNA methylation MN D'Souza, NKC Gowda, V Tiwari, RO Babu, P Anand, SG Dastidar, ... iScience 9, 399-411, 2018 | 28 | 2018 |
Inferring Sequence-Structure Preferences of RNA-Binding Proteins with Convolutional Residual Networks PK Koo, P Anand, SB Paul, SR Eddy bioRxiv, 418459, 2018 | 27 | 2018 |
Comprehensive characterization of circulating and bone marrow-derived multiple myeloma cells at minimal residual disease JM Waldschmidt, P Anand, B Knoechel, JG Lohr Seminars in hematology 55 (1), 33-37, 2018 | 27 | 2018 |
Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants AJ Venkatakrishnan, P Anand, PJ Lenehan, P Ghosh, R Suratekar, ... Scientific Reports 13 (1), 257, 2023 | 26* | 2023 |
High diversity in Delta variant across countries revealed by genome‐wide analysis of SARS‐CoV‐2 beyond the Spike protein R Suratekar, P Ghosh, MJM Niesen, G Donadio, P Anand, ... Molecular Systems Biology 18 (2), e10673, 2022 | 26 | 2022 |
Single-cell profiling reveals metabolic reprogramming as a resistance mechanism in BRAF-mutated multiple myeloma JM Waldschmidt, JA Kloeber, P Anand, J Frede, A Kokkalis, V Dimitrova, ... Clinical Cancer Research, 2021 | 23 | 2021 |
Characterizing the pocketome of Mycobacterium tuberculosis and application in rationalizing polypharmacological target selection P Anand, N Chandra Scientific reports 4, 6356, 2014 | 23 | 2014 |
PocketAnnotate: towards site-based function annotation P Anand, K Yeturu, N Chandra Nucleic Acids Research 40 (W1), W400-W408, 2012 | 22 | 2012 |